ARCHIVES

FDA carries Action On Two Cancer Drugs Over To 1996

This article is from The Cancer Letter archive.

Vol. 22 No. 01 | January 5, 1996

Download PDF Visit The Full Archive

Related Articles

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

Cancer.gov Knocked Offline By Theft Of Routers

July 11, 2003

Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products.

July 9, 2004

Orders Still Accepted For 20th Anniversary Special Publication

July 19, 1991

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010